Host: |
Rabbit |
Applications: |
IHC/IF/ELISA |
Reactivity: |
Human/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (1609-1658 aa) is suitable for use in Immunohistochemistry, Immunofluorescence and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
IHC 1:100-1:300ELISA 1:40000IF 1:50-200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
PPRC1 |
Gene ID: |
23082 |
Uniprot ID: |
PPRC1_HUMAN |
Immunogen Region: |
1609-1658 aa |
Specificity: |
PRC Polyclonal Antibody detects endogenous levels of PRC protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from the human PPRC1 at the amino acid range 1609-1658 |
Function | Acts as a coactivator during transcriptional activation of nuclear genes related to mitochondrial biogenesis and cell growth. Involved in the transcription coactivation of CREB and NRF1 target genes. |
Protein Name | Peroxisome Proliferator-Activated Receptor Gamma Coactivator-Related Protein 1Pgc-1-Related CoactivatorPrc |
Database Links | Reactome: R-HSA-2151201 |
Cellular Localisation | NucleusColocalizes With Nrf1 |
Alternative Antibody Names | Anti-Peroxisome Proliferator-Activated Receptor Gamma Coactivator-Related Protein 1 antibodyAnti-Pgc-1-Related Coactivator antibodyAnti-Prc antibodyAnti-PPRC1 antibodyAnti-KIAA0595 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance